메뉴 건너뛰기




Volumn 875, Issue 1, 2008, Pages 192-199

Enantiomerization of chiral 2,3,3a,4-tetrahydro-1H-pyrrolo[2,1-c][1,2,4]benzothiadiazine 5,5-dioxide by stopped-flow multidimensional HPLC

Author keywords

Enantiomerization; Free energy barriers; Rate constants; S18986; Stopped flow multidimensional HPLC method

Indexed keywords

CHIRALITY; CHROMATOGRAPHIC ANALYSIS; COLUMNS (STRUCTURAL); ENANTIOMERS; ENERGY BARRIERS; FREE ENERGY;

EID: 54049129637     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2008.05.009     Document Type: Article
Times cited : (17)

References (39)
  • 27
    • 0026437190 scopus 로고    scopus 로고
    • FDA's policy statement for the development of new stereoisomeric drugs, Chirality 4 (1992) 338.
    • FDA's policy statement for the development of new stereoisomeric drugs, Chirality 4 (1992) 338.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.